Health Care Equipment & Services

Guardant Health’s liquid‑tumor DNA platform (Guardant360 & Reveal) delivers early cancer detection, real‑time therapy guidance, and safe, non‑invasive monitoring—backed by FDA clearances and robust clinical data.

CLARITEV insider sale by Tiffani Misencik signals cautious optimism—examining regulatory impact, AI‑payment strategy, and market sentiment for investors.

Insight on Sylvia Young’s 18,500‑share sale at $26.62: why insider trading matters for PEDIATRIX’s bull‑market rally and what it signals for investors.

Insider buys at VAREX Imaging signal a strategic shift toward a diversified, service‑rich model, boosting confidence in its next‑gen X‑ray tech and AI integration.

Bluejay Diagnostics insider buying sparks hope of a turnaround amid steep stock decline and negative earnings. Explore what CEO & peers’ RSU purchases mean for investors.

QuidelOrtho insiders boost holdings with RSU buys while selling shares for tax cover, signalling long‑term confidence amid a 49% YTD decline.

Castle Biosciences CFO sale reveals a liquidity‑buffer strategy, not panic – insiders stay invested while dual‑listing boosts liquidity and long‑term prospects.

Alignment Healthcare insider sales rise—President Dawn Maroney sells 5,000 shares at $14, sparking concerns on valuation, growth, and future strategy.

Insider CFO buy of 10k Aclarion shares signals strong confidence in AI diagnostics, hinting at potential undervaluation and a buying opportunity.

Labcorp’s insider sale shows leadership pruning holdings while the company pushes tech‑driven diagnostics growth and plans Investor Day capital moves.